Pathovax

Prophylactic vaccine against all 15 oncogenic human papillomavirus.

placeBaltimore, Maryland, United States calendar_todayFounded 2014 groups3 employees language pathovax.com

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 34 times.

YearFilings
20181
20191
20201
20231
20241

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Accelerator & incubator240%
Other / undisclosed240%
Coming soon